Challenges to the Development of New Agents for Molecularly Defined Patient Subsets: Lessons From BRCA1/2-Associated Breast Cancer Presented in part at the 50th Annual Meeting and Exposition of the ...
Although rituximab (R) is commonly used for patients with advanced follicular lymphoma (FL) requiring treatment, the optimal associated chemotherapy regimen has yet to be clarified. The April 20, 2013 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results